<< Previous | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Next >>

QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection
Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment
Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients
A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection
Tipranavir/Ritonavir (TPV/r) in Protease Inhibitor (PI)-Experienced Patients With HIV-1 Infection
Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen
Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients
Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults
GW873140 In Combination With Combivir In HIV Infected Subjects
Emergency Use Program for HTE HIV+ Patients Who Need Tipranavir Treatment
Atazanavir for HIV Infected Individuals: An Early Access Program
A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

<< Previous | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Next >>